130 related articles for article (PubMed ID: 2194077)
21. Distribution of antiestrogen-specific binding sites in normal and neoplastic mammary gland.
Mehta RG; Cerny WL; Moon RC
Oncology; 1984; 41(6):387-92. PubMed ID: 6504492
[TBL] [Abstract][Full Text] [Related]
22. Nuclear binding of the estrogen receptor: heterogeneity of sites and uterotropic response.
Clark JH; Markaverich B; Upchurch S; Eriksson H; Hardin JW
Adv Exp Med Biol; 1979; 117():17-46. PubMed ID: 474276
[TBL] [Abstract][Full Text] [Related]
23. Relationship of hormone dependency to estrogen receptor and adenosine 3',5'-cyclic monophosphate-binding proteins in rat mammary tumors.
Bodwin JS; Clair T; Cho-Chung YS
J Natl Cancer Inst; 1980 Feb; 64(2):395-8. PubMed ID: 6928231
[TBL] [Abstract][Full Text] [Related]
24. Binding of estrogen receptor from N-nitrosomethylurea-induced rat mammary tumors to nuclei.
Dietrich W; Görlich M; Heise E
Eur J Cancer Clin Oncol; 1986 Feb; 22(2):181-90. PubMed ID: 3084262
[TBL] [Abstract][Full Text] [Related]
25. Influence of prenatal exposure to diethylstilbestrol on estrogen and progestin binding proteins in uteri and dimethylbenzanthracene- induced mammary tumors of the rat.
Heidemann PH; Wittliff JL; Calhoon RE; Boylan ES
J Toxicol Environ Health; 1981 Oct; 8(4):667-86. PubMed ID: 6802985
[TBL] [Abstract][Full Text] [Related]
26. An endogenous inhibitor of [3H]estradiol binding to nuclear type II estrogen binding sites in normal and malignant tissues.
Markaverich BM; Roberts RR; Alejandro MA; Clark JH
Cancer Res; 1984 Apr; 44(4):1515-9. PubMed ID: 6704964
[TBL] [Abstract][Full Text] [Related]
27. Activation of the estrogen receptor from N-nitrosomethylurea-induced rat mammary tumors.
Dietrich W; Görlich M; Helbing D; Heise E
J Steroid Biochem; 1988 Jan; 29(1):77-85. PubMed ID: 3347053
[TBL] [Abstract][Full Text] [Related]
28. The effect of GH on estrogen receptor expression in the rat mammary gland.
Feldman M; Ruan W; Tappin I; Wieczorek R; Kleinberg DL
J Endocrinol; 1999 Dec; 163(3):515-22. PubMed ID: 10588825
[TBL] [Abstract][Full Text] [Related]
29. Growth and characterization of N-methyl-N-nitrosourea-induced mammary tumors in intact and ovariectomized rats.
Thordarson G; Lee AV; McCarty M; Van Horn K; Chu O; Chou YC; Yang J; Guzman RC; Nandi S; Talamantes F
Carcinogenesis; 2001 Dec; 22(12):2039-47. PubMed ID: 11751437
[TBL] [Abstract][Full Text] [Related]
30. Effect of estrogenic perturbations on delta-aminolevulinic acid-induced porphobilinogen deaminase and protoporphyrin IX levels in rat Harderian glands, liver, and R3230AC tumors.
Gibson SL; Anderson LT; Havens JJ; Hilf R
Biochem Pharmacol; 1999 Dec; 58(11):1821-9. PubMed ID: 10571258
[TBL] [Abstract][Full Text] [Related]
31. Steroid-hormone-binding proteins in normal and neoplastic mammary tissues from C3H mice fed diethylstilbestrol.
Lewko WM; Wittliff JL
J Toxicol Environ Health; 1983 Jul; 12(1):127-41. PubMed ID: 6632000
[TBL] [Abstract][Full Text] [Related]
32. Application of a mathematical model for two component receptor binding to two high affinity oestrogen binding sites in nuclei from DMBA rat mammary tumours.
Clark ER; Mackay D; Robinson SP
J Steroid Biochem; 1988 Apr; 29(4):375-80. PubMed ID: 3131591
[TBL] [Abstract][Full Text] [Related]
33. Morphology, growth characteristics and oestrogen-binding capacity of DMBA-induced mammary tumours from ovariectomized rats.
Boylan ES; Fowler EH; Wittliff JL
Br J Cancer; 1977 May; 35(5):602-9. PubMed ID: 405032
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the physicochemical properties of uterine nuclear estrogen receptors bound to estradiol or 4-hydroxytamoxifen.
Attardi B; Happe HK
Endocrinology; 1986 Aug; 119(2):904-15. PubMed ID: 3732150
[TBL] [Abstract][Full Text] [Related]
35. Antiestrogen binding sites in rat liver nuclei.
Kon OL
Biochim Biophys Acta; 1985 Dec; 843(3):245-53. PubMed ID: 4063396
[TBL] [Abstract][Full Text] [Related]
36. Characterization of a unique nuclear estrogen-binding component in an estrogen-responsive mouse Leydig cell tumor.
Maeda Y; Sato B; Noma K; Kishimoto S; Koizumi K; Aono T; Matsumoto K
Cancer Res; 1983 Sep; 43(9):4091-7. PubMed ID: 6871850
[TBL] [Abstract][Full Text] [Related]
37. Preliminary characterization of an endogenous inhibitor of [3H]estradiol binding in rat uterine nuclei.
Markaverich BM; Roberts RR; Finney RW; Clark JH
J Biol Chem; 1983 Oct; 258(19):11663-71. PubMed ID: 6619136
[TBL] [Abstract][Full Text] [Related]
38. Comparative studies on estrogen receptors between a pregnancy-dependent mouse mammary tumor (TPDMT-4) and related autonomous tumors.
Matsuzawa A; Hayakawa T; Takitani S; Iwaguchi T
Endocrinology; 1987 Jun; 120(6):2346-56. PubMed ID: 3569134
[TBL] [Abstract][Full Text] [Related]
39. Nuclear association states of rat uterine oestrogen receptors as probed by nuclease digestion.
Schoenberg DR; Clark JH
Biochem J; 1981 May; 196(2):423-32. PubMed ID: 6274314
[TBL] [Abstract][Full Text] [Related]
40. Antagonism of development and growth of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors by the antiestrogen U 23,469 and effects on estrogen and progesterone receptors.
Tsai TL; Katzenellenbogen BS
Cancer Res; 1977 May; 37(5):1537-43. PubMed ID: 404032
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
